Roles of Fas and Fas ligand during mammary gland remodeling

Journal of Clinical Investigation

Volumn 106, Issue 10, 2000, Pages 1209-1220

  Song, Joon ^a   Sapi, Eva ^a   Brown, Wendi ^a   Nilsen, Jon ^a   Tartaro, Karrie ^b   Kacinski, Barry M ^a,b   Craft, Joseph ^b   Naftolin, Frederick ^a   Mor, Gil ^a,b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; FAS ANTIGEN; FAS LIGAND; PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BREAST CELL; BREAST EPITHELIUM; CONTROLLED STUDY; EPITHELIUM CELL; HORMONAL REGULATION; HUMAN; HUMAN CELL; LACTATION; MAMMARY GLAND; MOUSE; NONHUMAN; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; WEANING;

EID: 0033721135     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10411     Document Type: Article

References (63)

1. Age at first birth, parity and risk of breast cancer: A metaanalysis of 8 studies from Nordic countries
2. Breast cancer
3. History of lactation and breast cancer risk
4. Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression
5. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice
6. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice
7. Deacetylase activity of human tumor cells producing immunosuppressive aminosugars: Its possible role in resistance to cell-mediated cytotoxicity
8. Gangliosides and antitumor immunity
9. Comparison of cell lines deficient in antigen presentation reveals a functional role for TAP-1 alone in antigen processing
10. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
11. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
12. Role for CD95 ligand in preventing graft rejection
13. Fas ligand induced apoptosis as a mechanism of immune privilege
14. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells
15. The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces
16. Fas-Fas ligand system induced apoptosis in human placenta and gestational trophoblastic disease
17. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain-evidence for the existence of an immunological brain barrier
18. The Fas/Fas-ligand system: A mechanism for immune evasion in human breast carcinomas
19. Human lung carcinomas express Fas ligand
20. Apoptosis and apoptosis-related proteins in the epithelium of human ovarian tumors: Immunohistochemical and morphometric studies
21. Constitutive expression of Fas (Apo-1/Cd95) ligand on multiple myeloma cells: A potential mechanism of tumor-induced suppression of immune surveillance
22. Growth factors in breast cancer
23. Regulation of p53 and its targets during involution of the mammary gland
24. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver
25. Generalized lymphoproliferative disease in mice, caused by point mutation in the Fas ligand
26. Macrophage-derived growth factors regulate FasL expression in endometrial stromal cells
27. Regulation of Fas ligand expression in breast cancer cells by estrogen: Functional differences between estradiol and tamoxifen
28. Lymphocyte apoptosis induced by CD95 (APO-1 Fas) ligand-expressing tumor cells - A mechanism of immune evasion?
29. The JAM test
30. Expression of CSF-1 and CSF-1 receptor by normal lactating mammary epithelial cells
31. Cell death by apoptosis during involution of the lactating breast in mice and rats
32. Hormone-induced cell death. 2. Surface changes in thymocytes undergoing apoptosis
33. Macrophage recognition of cells undergoing programmed cell death
34. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
35. Apoptosis in lactating and involuting mouse mammary tissue demonstrated by nick-end DNA labelling
36. Programmed cell death during mammary tissue involution induced by weaning, litter removal, and milk stasis
37. Mammary plasminogen activator: Correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue
38. Programmed cell death during mammary gland involution
39. Fas and Fas ligand: A death factor and its receptor
40. The Fas death factor
41. Illegitimate transcription: Its use in the study of inherited disease
42. Illegitimate transcription. Application to the analysis of truncated transcripts of the dystrophin gene in nonmuscle cultured cells from Duchenne and Becker patients
43. Illegitimate transcription: Transcription of any gene in any cell type
44. Apoptotic cell death and tissue remodeling during mouse mammary gland involution
45. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice
46. Two distinct phases of apoptosis in mammary gland involution: Proteinase-independent and -dependent pathways
47. Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution
48. Introduction: Mammary gland involution and apoptosis of mammary epithelial cells
49. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix
50. P53-dependent DNA damage-induced apoptosis requires Fas/Apo-1-independent activation of Cpp32-beta
51. Inhibition of interleukin-1beta-converting enzyme in human hematopoietic progenitor cells results in blockade of cytokine-mediated apoptosis and expansion of their proliferative potential
52. p53 Activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
53. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO- 1/Fas) receptor/ligand system and involves activation of wild-type p53
54. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis
55. Paneth cells express high levels of CD9S ligand transcripts: A unique property among gastrointestinal epithelia
56. Decreased Fas antigen receptor expression in testicular tumor cell lines derived from polyomavirus large T-antigen transgenic mice
57. Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape
58. Fas expression and function in normal and malignant breast cell lines
59. Biological and molecular basis of human breast cancer
60. The role of CSF-1 in normal and neoplastic breast physiology
61. Fas antigen-mediated apoptosis of ovarian surface epithelial cells
62. Apoptosis and apoptosis-related proteins (Fas, Fas ligand, bcl-2, p53) in macrophages of human ovarian epithelial tumors
63. Apoptosis and apoptosis-related proteins (Fas, Fas ligand, Blc-2, p53) in lymphoid elements of human ovarian tumors